I have learned through experience not to follow broker ratings however any comments on this. NST are a key investment in my PF so just putting this out to comments, Credit Suisse say:
"First-half net profit beat Credit Suisse estimates because of toll treatment contributions that were not discernible from the quarterly reports.FY20 guidance is unchanged and a stronger second half is expected.? Underperform rating and $10.30 target maintained.Sector: Materials.Target price is $10.30.Current Price is $13.67. Difference: ($3.37) – (brackets indicate current price is over target). If NST meets the Credit Suisse target it will return approximately -33% (excluding dividends, fees and charges – negative figures indicate an expected loss)."
- Forums
- ASX - By Stock
- NST
- Credit Suisse Re-rating
Credit Suisse Re-rating
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.55 |
Change
-0.450(2.65%) |
Mkt cap ! $19.02B |
Open | High | Low | Value | Volume |
$16.31 | $16.67 | $16.24 | $65.39M | 3.968M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5075 | $16.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.55 | 9220 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5075 | 16.520 |
3 | 3501 | 16.510 |
1 | 4000 | 16.490 |
2 | 3792 | 16.480 |
2 | 803 | 16.450 |
Price($) | Vol. | No. |
---|---|---|
16.550 | 9220 | 3 |
16.560 | 19802 | 2 |
16.570 | 7682 | 1 |
16.580 | 21506 | 3 |
16.610 | 11072 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online